Company Filing History:
Years Active: 2002
Title: Miwa Ikeda: Innovator in Human Growth Hormone Therapy
Introduction
Miwa Ikeda is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of medical science, particularly in the therapeutic use of human growth hormones. Her innovative work has the potential to improve the quality of life for many individuals.
Latest Patents
Miwa Ikeda holds a patent for the therapeutic use of a 20-kilodalton human growth hormone. This patent describes the administration of an authentic human growth hormone with a molecular weight of 20,000 daltons to human adults. The application of this hormone can improve body composition, stimulate lipolysis, increase serum insulin-like growth factor I, and serve as a replacement therapy for patients deficient in human growth hormone.
Career Highlights
Ikeda is associated with Schering Aktiengesellschaft, a company known for its advancements in pharmaceuticals. Her work has been instrumental in developing therapies that address growth hormone deficiencies, showcasing her dedication to medical innovation.
Collaborations
Throughout her career, Miwa Ikeda has collaborated with notable colleagues, including Noriaki Asada and Masaru Honjo. These partnerships have furthered her research and contributed to the success of her projects.
Conclusion
Miwa Ikeda's contributions to the field of human growth hormone therapy highlight her role as an influential inventor. Her innovative patent and collaborations reflect her commitment to advancing medical science and improving patient care.